Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background Hidradenitis suppurativa (HS) is a chronic cutaneous disease with acutely painful flares. In a prior study of all-cause utilization, patients with HS had higher utilization of emergency department (ED) and inpatient care. Objective We sought to assess utilization of medical care specifically related to HS, especially high-cost settings. Methods The MarketScan medical claims database was examined for participants with either HS or psoriasis based on International Classification of Diseases, Ninth Revision codes, during the study period, January 2008 to December 2012. This was a cohort cost-identification study with analyses of utilization measures and direct costs. Results The proportion of the HS cohort hospitalized was 5.1% and was higher than the psoriasis cohort (1.6%) (P <.0001). The proportion of patients who used the ED was also higher in the HS cohort (7.4% vs 2.6%, P <.0001). When compared with a subset of patients with severe psoriasis, the proportions of patients with HS who used the ED (7.4% vs 4.2%, P <.0001) or inpatient care (5.1% vs 2.5%, P <.0001) remained elevated. Limitations The study sample may not be generalizable to other patient populations and may represent those with more severe disease. Pharmaceutical costs were not included and confounding factors such as race, socioeconomic status, and insurance type were not investigated. Conclusion Patients with HS had increased utilization of high-cost settings, such as the ED and inpatient care, compared with patients with psoriasis, another chronic inflammatory disease. Both patients and providers should be aware of this finding and further work is needed to incorporate assessment of patient outcomes.

Original languageEnglish (US)
Pages (from-to)609-614
Number of pages6
JournalJournal of the American Academy of Dermatology
Volume73
Issue number4
DOIs
StatePublished - Oct 1 2015

Fingerprint

Hidradenitis Suppurativa
Hospital Emergency Service
Inpatients
Patient Care
Psoriasis
Costs and Cost Analysis
Chronic Disease
Patient Outcome Assessment
International Classification of Diseases
Insurance
Skin Diseases
Social Class
Databases

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

@article{5a0417ffe6f8420ba559b3d6eff731f7,
title = "Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa",
abstract = "Background Hidradenitis suppurativa (HS) is a chronic cutaneous disease with acutely painful flares. In a prior study of all-cause utilization, patients with HS had higher utilization of emergency department (ED) and inpatient care. Objective We sought to assess utilization of medical care specifically related to HS, especially high-cost settings. Methods The MarketScan medical claims database was examined for participants with either HS or psoriasis based on International Classification of Diseases, Ninth Revision codes, during the study period, January 2008 to December 2012. This was a cohort cost-identification study with analyses of utilization measures and direct costs. Results The proportion of the HS cohort hospitalized was 5.1{\%} and was higher than the psoriasis cohort (1.6{\%}) (P <.0001). The proportion of patients who used the ED was also higher in the HS cohort (7.4{\%} vs 2.6{\%}, P <.0001). When compared with a subset of patients with severe psoriasis, the proportions of patients with HS who used the ED (7.4{\%} vs 4.2{\%}, P <.0001) or inpatient care (5.1{\%} vs 2.5{\%}, P <.0001) remained elevated. Limitations The study sample may not be generalizable to other patient populations and may represent those with more severe disease. Pharmaceutical costs were not included and confounding factors such as race, socioeconomic status, and insurance type were not investigated. Conclusion Patients with HS had increased utilization of high-cost settings, such as the ED and inpatient care, compared with patients with psoriasis, another chronic inflammatory disease. Both patients and providers should be aware of this finding and further work is needed to incorporate assessment of patient outcomes.",
author = "Greene, {Amrit {"}Ami{"} Khalsa} and Guodong Liu and {Sciacca Kirby}, Joslyn",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.jaad.2015.06.053",
language = "English (US)",
volume = "73",
pages = "609--614",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa

AU - Greene, Amrit "Ami" Khalsa

AU - Liu, Guodong

AU - Sciacca Kirby, Joslyn

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background Hidradenitis suppurativa (HS) is a chronic cutaneous disease with acutely painful flares. In a prior study of all-cause utilization, patients with HS had higher utilization of emergency department (ED) and inpatient care. Objective We sought to assess utilization of medical care specifically related to HS, especially high-cost settings. Methods The MarketScan medical claims database was examined for participants with either HS or psoriasis based on International Classification of Diseases, Ninth Revision codes, during the study period, January 2008 to December 2012. This was a cohort cost-identification study with analyses of utilization measures and direct costs. Results The proportion of the HS cohort hospitalized was 5.1% and was higher than the psoriasis cohort (1.6%) (P <.0001). The proportion of patients who used the ED was also higher in the HS cohort (7.4% vs 2.6%, P <.0001). When compared with a subset of patients with severe psoriasis, the proportions of patients with HS who used the ED (7.4% vs 4.2%, P <.0001) or inpatient care (5.1% vs 2.5%, P <.0001) remained elevated. Limitations The study sample may not be generalizable to other patient populations and may represent those with more severe disease. Pharmaceutical costs were not included and confounding factors such as race, socioeconomic status, and insurance type were not investigated. Conclusion Patients with HS had increased utilization of high-cost settings, such as the ED and inpatient care, compared with patients with psoriasis, another chronic inflammatory disease. Both patients and providers should be aware of this finding and further work is needed to incorporate assessment of patient outcomes.

AB - Background Hidradenitis suppurativa (HS) is a chronic cutaneous disease with acutely painful flares. In a prior study of all-cause utilization, patients with HS had higher utilization of emergency department (ED) and inpatient care. Objective We sought to assess utilization of medical care specifically related to HS, especially high-cost settings. Methods The MarketScan medical claims database was examined for participants with either HS or psoriasis based on International Classification of Diseases, Ninth Revision codes, during the study period, January 2008 to December 2012. This was a cohort cost-identification study with analyses of utilization measures and direct costs. Results The proportion of the HS cohort hospitalized was 5.1% and was higher than the psoriasis cohort (1.6%) (P <.0001). The proportion of patients who used the ED was also higher in the HS cohort (7.4% vs 2.6%, P <.0001). When compared with a subset of patients with severe psoriasis, the proportions of patients with HS who used the ED (7.4% vs 4.2%, P <.0001) or inpatient care (5.1% vs 2.5%, P <.0001) remained elevated. Limitations The study sample may not be generalizable to other patient populations and may represent those with more severe disease. Pharmaceutical costs were not included and confounding factors such as race, socioeconomic status, and insurance type were not investigated. Conclusion Patients with HS had increased utilization of high-cost settings, such as the ED and inpatient care, compared with patients with psoriasis, another chronic inflammatory disease. Both patients and providers should be aware of this finding and further work is needed to incorporate assessment of patient outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84941599734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941599734&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2015.06.053

DO - 10.1016/j.jaad.2015.06.053

M3 - Article

C2 - 26190241

AN - SCOPUS:84941599734

VL - 73

SP - 609

EP - 614

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 4

ER -